Literature DB >> 17584618

Substrate-dependent targeting of eukaryotic translation initiation factor 4A by pateamine A: negation of domain-linker regulation of activity.

Woon-Kai Low1, Yongjun Dang, Shridhar Bhat, Daniel Romo, Jun O Liu.   

Abstract

Central to cap-dependent eukaryotic translation initiation is the eIF4F complex, which is composed of the three eukaryotic initiation factors eIF4E, eIF4G, and eIF4A. eIF4A is an RNA-dependent ATPase and an ATP-dependent helicase that unwinds local secondary structure in mRNA to allow binding of the 43S ribosomal complex. The marine natural product pateamine A (PatA) has been demonstrated to inhibit cap-dependent initiation by targeting eIF4A and disrupting its protein-protein interactions while increasing its enzymatic activities. Here we demonstrate that the increased activity is caused by the induction of global conformational changes within eIF4A. Furthermore, binding of PatA is dependent on substrate (RNA and ATP) binding, and the increased activity upon PatA binding is caused by relief of a negative regulatory function of the eIF4A unique domain linker.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17584618     DOI: 10.1016/j.chembiol.2007.05.012

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  22 in total

1.  Emerging therapeutics targeting mRNA translation.

Authors:  Abba Malina; John R Mills; Jerry Pelletier
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

Review 2.  Natural products as chemical probes.

Authors:  Erin E Carlson
Journal:  ACS Chem Biol       Date:  2010-07-16       Impact factor: 5.100

3.  Inhibition of nonsense-mediated mRNA decay by the natural product pateamine A through eukaryotic initiation factor 4AIII.

Authors:  Yongjun Dang; Woon-Kai Low; Jing Xu; Niels H Gehring; Harry C Dietz; Daniel Romo; Jun O Liu
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

Review 4.  Target profiling of small molecules by chemical proteomics.

Authors:  Uwe Rix; Giulio Superti-Furga
Journal:  Nat Chem Biol       Date:  2009-09       Impact factor: 15.040

5.  Structural analysis of the spliceosomal RNA helicase Prp28 from the thermophilic eukaryote Chaetomium thermophilum.

Authors:  Marcel J Tauchert; Ralf Ficner
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-04-22       Impact factor: 1.056

6.  Second-generation derivatives of the eukaryotic translation initiation inhibitor pateamine A targeting eIF4A as potential anticancer agents.

Authors:  Woon-Kai Low; Jing Li; Mingzhao Zhu; Sai Shilpa Kommaraju; Janki Shah-Mittal; Ken Hull; Jun O Liu; Daniel Romo
Journal:  Bioorg Med Chem       Date:  2013-12-04       Impact factor: 3.641

7.  Bridging the gap between natural product synthesis and drug discovery.

Authors:  Nathanyal J Truax; Daniel Romo
Journal:  Nat Prod Rep       Date:  2020-10-26       Impact factor: 13.423

Review 8.  Therapeutic Opportunities in Eukaryotic Translation.

Authors:  Jennifer Chu; Jerry Pelletier
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

9.  The eIF4AIII RNA helicase is a critical determinant of human cytomegalovirus replication.

Authors:  Ben Ziehr; Erik Lenarcic; Chad Cecil; Nathaniel J Moorman
Journal:  Virology       Date:  2016-01-08       Impact factor: 3.616

10.  Potent in vitro and in vivo anticancer activities of des-methyl, des-amino pateamine A, a synthetic analogue of marine natural product pateamine A.

Authors:  Galina Kuznetsov; Qunli Xu; Lori Rudolph-Owen; Karen Tendyke; Junke Liu; Murray Towle; Nanding Zhao; Joanne Marsh; Sergei Agoulnik; Natalie Twine; Lana Parent; Zhihong Chen; Jue-Lon Shie; Yimin Jiang; Huiming Zhang; Hong Du; Roch Boivin; Yuan Wang; Daniel Romo; Bruce A Littlefield
Journal:  Mol Cancer Ther       Date:  2009-05-05       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.